Sponsor
Byondis B.V.
Microweg 22, 6545 CM Nijmegen, The Netherlands
About the sponsor
Byondis B.V. focuses on relapsed/refractory acute myeloid leukemia and myelodysplastic neoplasms, with clinical activity centered on treatment-resistant blood cancers. Its research also includes CD20-positive B-cell non-Hodgkin’s lymphoma, reflecting an interest in malignancies where immune-targeted approaches may be relevant.
- Acute myeloid leukemia
- Myelodysplastic neoplasms
- CD20-positive B-cell non-Hodgkin’s lymphoma
The sponsor’s work in this area is linked to clinical development programs aimed at difficult-to-treat hematologic cancers.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.